News Releases

Anixa Biosciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference

September 8, 2020

Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds

August 13, 2020

Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission

July 28, 2020

Anixa Biosciences Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders

July 20, 2020

Anixa Biosciences' CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office

July 10, 2020

Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds

July 6, 2020

Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic and Vaccine Pipeline

July 2, 2020

Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for Testing in Biological Assays

June 1, 2020

Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate

May 4, 2020

Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Biomarker Insights Highlighting Cchek™ Liquid Biopsy Technology

April 23, 2020

« Previous
1
2
3
4
5
6
7
8
9
10
...18
Next »

Latest News & Events

May 26, 2021

Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic

Read More...

May 20, 2021

Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application

Read More...

May 7, 2021

OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie

Read More...